STAT5 outcompetes STAT3 to regulate the expression of the oncogenic transcriptional modulator BCL6

Area of Science:

• Oncology
• Molecular Biology
• Gene Regulation

Background:

• Signal transducer and activator of transcription (STAT) proteins, specifically STAT3 and STAT5, are implicated in cancer development by altering genes controlling cell growth and survival.
• While structurally similar, STAT3 and STAT5 can exert opposing regulatory effects on critical genes like BCL6, a known oncogene in certain lymphomas and important in breast cancer.
• Both STAT3 and STAT5 can be activated in breast cancer, individually or together, highlighting the need to understand their combined regulatory mechanisms.

Purpose of the Study:

• To elucidate the molecular mechanisms by which STAT3 and STAT5 transcription factors regulate BCL6 gene expression.
• To investigate the impact of STAT3 and STAT5 on chromatin and gene expression related to BCL6.

Main Methods:

• Analysis of chromatin and gene expression levels.
• Assessment of RNA polymerase II recruitment and phosphorylation at the BCL6 gene locus.
• Investigation of STAT protein interactions and displacement at regulatory regions.

Main Results:

• STAT3 activation leads to increased BCL6 expression and enhanced recruitment of initiating RNA polymerase II.
• STAT5 activation represses BCL6 expression below basal levels and reduces RNA polymerase II association with the gene.
• STAT5-mediated repression of BCL6 is dominant over STAT3-induced expression, achieved by STAT5 displacing STAT3 from a regulatory binding site.

Conclusions:

• STAT3 and STAT5 exhibit opposing transcriptional control over the BCL6 gene.
• STAT5's dominant repressive effect on BCL6, achieved through competitive binding, provides a molecular basis for distinct breast cancer subtypes.
• These findings offer insights into the divergent roles of STAT3 and STAT5 in breast cancer pathogenesis.